Citi Trends, (CTRN) Institutional Ownership
Track institutional investors, ownership changes, and 13F filings.
Ownership Summary
Total Institutions
85
Total Shares Held
8.11M
Total Value
$212.79M
Institutional Holding %
97.01%
Ownership Distribution
Top 5 Holders
Top Institutional Holders (as of Dec 31, 2024)
Institution | Shares | Ownership % | Value |
---|---|---|---|
FUND 1 | 2.57M | 30.80% | $67.55M |
LONG FOCUS | 556.46K | 6.66% | $14.61M |
BlackRock | 543.30K | 6.50% | $14.26M |
DIMENSIONAL FUND | 533.27K | 6.38% | $14.00M |
377.88K | 4.52% | $9.92M | |
SHAY | 360.00K | 4.31% | $9.45M |
VANGUARD | 349.11K | 4.18% | $9.16M |
AWM COMPANY | 228.78K | 2.74% | $6.01M |
PARADIGM | 200.00K | 2.39% | $5.25M |
AMERIPRISE FINANCIAL | 198.89K | 2.38% | $5.22M |
Recent Insider Trading
Insider | Title | Transaction | Shares | Value | Date |
---|---|---|---|---|---|
Duskin Jonathan | Director | S-Sale | 12.00K | $317.27K | Dec 26, 2024 |
George Katrina | Vp Of Human Resources | S-Sale | 262 | $7.04K | Dec 18, 2024 |
Seipel Kenneth Duane | Director, Chief Executive Officer | A-Award | 321.50K | $- | Nov 18, 2024 |
Seipel Kenneth Duane | Director, Chief Executive Officer | A-Award | 80.00K | $- | Nov 18, 2024 |
Seipel Kenneth Duane | Director, Interim Ceo | A-Award | 3.64K | $- | Nov 02, 2024 |
George Katrina | Vp Of Human Resources | D-Return | 452 | $10.89K | Oct 31, 2024 |
Seipel Kenneth Duane | Director, Interim Ceo | A-Award | 3.64K | $- | Oct 02, 2024 |
Heath David A | Director | P-Purchase | 1.50K | $21.88K | Sep 10, 2024 |
Plutino Heather L | Evp And Cfo | P-Purchase | 3.57K | $49.99K | Sep 04, 2024 |
Seipel Kenneth Duane | Director, Interim Ceo | A-Award | 3.64K | $- | Sep 02, 2024 |
Recent Position Changes
Institution | Shares Changed | % Change | Date |
---|---|---|---|
AWM COMPANY | -322.57K | -58.51% | Feb 18, 2025 |
+160.52K | +73.85% | Feb 14, 2025 | |
JPMorgan CHASE | +149.65K | +5400.61% | Feb 12, 2025 |
VANGUARD | -110.62K | -24.06% | Feb 11, 2025 |
SHAY | +102.96K | +40.05% | Feb 14, 2025 |
GENERAL EQUITY | +94.18K | +100.00% | Feb 14, 2025 |
GOLDMANCHS | +75.00K | +100.00% | Feb 11, 2025 |
ASSENAGON ASSET S.A. | -67.29K | -79.32% | Jan 14, 2025 |
PARADIGM | -56.53K | -22.04% | Feb 18, 2025 |
CHARLES SCHWAB | -51.19K | -41.95% | Feb 06, 2025 |
Recent Ownership Filings
4
Form 4 - Statement of changes in beneficial ownership of securities
Dec 27, 2024
144
Form 144 - Report of proposed sale of securities
Dec 26, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Dec 19, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Dec 06, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Dec 06, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Nov 20, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Nov 05, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Nov 04, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 04, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Oct 03, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Sep 11, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Sep 04, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Sep 04, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Aug 30, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Aug 29, 2024
144
Form 144 - Report of proposed sale of securities
Aug 08, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Aug 06, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Jul 17, 2024
Related Metrics
Explore detailed financial metrics and analysis for CTRN.